These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8358346)

  • 1. In vitro and in vivo testing of the dopamine D1 ligand [123I]SCH 23982 with respect to its potential application in SPET investigations.
    Beer HF; Lin S; Bläuenstein P; Hasler P; Schubiger PA; Maier A; Lichtensteiger W; Oettli R; Bekier A; Weder B
    Nucl Med Biol; 1993 Jul; 20(5):607-16. PubMed ID: 8358346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-SCH 23982 is not suitable for dopamine D1 receptor imaging in vivo in the human brain.
    Verhoeff NP; Bekier A; Beer HF; Schubiger PA; Fennema P; van Royen EA
    Nucl Med Commun; 1993 Feb; 14(2):137-44. PubMed ID: 8429993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of (+)-2- [123I]A-69024: a radioligand for in vivo studies of dopamine D1 receptors.
    Kassiou M; Mardon K; Mattner F; Katsifis A; Dikic B
    Life Sci; 2001 Jun; 69(6):669-75. PubMed ID: 11476188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging.
    Moerlein SM; Parkinson D; Welch MJ
    Int J Rad Appl Instrum A; 1990; 41(4):381-5. PubMed ID: 2158956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortex.
    Hughes A; Sever P
    Biochem Pharmacol; 1989 Mar; 38(5):781-5. PubMed ID: 2522780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand.
    Dawson TM; Barone P; Sidhu A; Wamsley JK; Chase TN
    Neuroscience; 1988 Jul; 26(1):83-100. PubMed ID: 2971144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
    Chu J; Wilczynski W; Wilcox RE
    Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [125I]SCH 23982 binding in human brain: comparison with [3H]SCH 23390.
    Laruelle M; Sidhu A; Casanova MF; Weinberger DR; Kleinman JE
    Neurosci Lett; 1991 Oct; 131(2):273-6. PubMed ID: 1837073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and radiation dosimetry of radioiodinated-SCH 23982, a potential dopamine D-1 receptor imaging agent.
    Thonoor CM; Couch MW; Greer DM; Thomas KD; Williams CM
    J Nucl Med; 1988 Oct; 29(10):1668-74. PubMed ID: 3262726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB; O'Boyle KM
    Eur J Pharmacol; 1994 Jun; 268(1):79-88. PubMed ID: 7925614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.
    Porceddu ML; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Dec; 118(3):367-70. PubMed ID: 2935413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
    Hoyer D; Karpf A
    Eur J Pharmacol; 1988 May; 150(1-2):181-4. PubMed ID: 3402537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-melanotropin hormone inhibits the binding of [3H]SCH 23390 to the dopamine D1 receptor in vitro.
    Lezcano NE; Salvatierra NA; Celis ME
    Eur J Pharmacol; 1998 Dec; 363(2-3):211-5. PubMed ID: 9881592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
    Monsma FJ; Sibley DR
    Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
    Sidhu A; van Oene JC; Dandridge P; Kaiser C; Kebabian JW
    Eur J Pharmacol; 1986 Sep; 128(3):213-20. PubMed ID: 2947806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
    Karlsson P; Sedvall G; Halldin C; Swahn CG; Farde L
    Psychopharmacology (Berl); 1995 Oct; 121(3):300-8. PubMed ID: 8584610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large scale preparation strategy for labelling of [123I]-SCH 23982, a dopamine D1 receptor binding agent.
    Beer HF; Lin S; Novak-Hofer I; Bläuenstein P; Schubiger PA
    Int J Rad Appl Instrum A; 1992 Jun; 43(6):781-7. PubMed ID: 1319421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.